NCT00532922已完成不适用
A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 310
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to investigate real practices of treatment with Symbicort Turbuhaler for 3 months in asthma and patient compliance.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 6 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Provision of informed consent
- •Asthmatics who has been prescribed Symbicort according to physician's judgement
- •Usage of Symbicort should follow local prescribing information
排除标准
- •Not being involved in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site)
- •No previous enrolment in the present study
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMARTModerate/Severe AsthmaNCT00785733AstraZeneca1,182
已完成
不适用
Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in FranceAsthmaNCT00812357AstraZeneca579
已完成
不适用
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily PracticeAsthmaNCT00782314AstraZeneca400
已完成
3 期
A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in JapanChronic Obstructive Pulmonary DiseaseNCT01070784AstraZeneca328
已完成
3 期
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaAsthmaNCT00255255AstraZeneca120